BioCentury
ARTICLE | Clinical News

ALKS 3831: Phase I data

January 21, 2013 8:00 AM UTC

A double-blind, placebo- and active-controlled Phase I trial in 106 healthy volunteers showed that subjects receiving once-daily oral ALKS 3831 had significantly less mean weight gain from baseline to...